EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism

Rocio Diaz Escarcega, Vijay Kumar M J, Vasilia E Kyriakopoulos, Guadalupe J Ortiz, Aaron M Gusdon, Huihui Fan, Pedram Peesh, Maria P Blasco Conesa, Gabriela Delevati Colpo, Hilda W Ahnstedt, Lucy Couture, Stella H Kim und 8 weitere

Neurobiology of Disease · 2025

DOI: 10.1016/j.nbd.2024.106747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Rocio Diaz Escarcega und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, the University of Texas McGovern Medical School at Houston, TX, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Lipid Metabolism, Sex Characteristics, Metabolome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) affects more women than men. Although women live longer than men, it is not longevity alone, but other factors, including metabolic changes, that contribute to the higher risk of AD in women. Metabolic pathways have been implicated in AD progression, but studies to date examined targeted pathways, leaving many metabolites unmeasured. Sex is often a neglected biological variable, and most metabolomic studies were not designed to investigate sex differences in metabolomic profiles. Here, we performed untargeted metabolomic profiling of sera from male and female patients with mild cognitive impairment (MCI), a common precursor to AD, and matched controls. We discovered significant metabolic changes in individuals with MCI, and found several pathways that were strongly associated with sex. Peptide energy metabolism demonstrated sexual dimorphism. Lipid pathways exhibited the strongest differences between female and male MCI patients, including specific phosphatidylcholine lipids, lysophospholipids, long-chain fatty acids, and monoacylglycerols. 1-palmitoleoyl glycerol and 1-arachidonoyl glycerol were higher in female MCI subjects than in male MCI subjects with no differences between control males and females. Conversely, specific dicarboxylic fatty acids were lower in female MCI subjects than male MCI subjects. In cultured astrocytes, 1-arachidonoyl glycerol promoted phosphorylation of the transcriptional regulator sphingosine kinase 2, which was inhibited by the transient receptor potential vanilloid 1 receptor antagonists, as well as chromatin remodelling. Overall, we identified novel sex-specific metabolites in MCI patients that could serve as biomarkers of MCI in both sexes, help further define AD etiology, and reveal new potential prevention strategies for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionLipid MetabolismSex CharacteristicsMetabolomeHumansMaleFemaleAgedMiddle AgedAged, 80 and overAlzheimer Disease

Stichwörter der Autor:innen

1-MonoacylglycerolCognitionG-quadruplexLipidsMetabolomicsSex differencesSphingosine kinase 2

Autor:innen und Institutionen

  • Department of Neurology, the University of Texas McGovern Medical School at Houston, TX, USA.
  • Department of Neurosurgery, the University of Texas McGovern Medical School at Houston, TX, USA.
  • Department of Neurology, the University of Texas McGovern Medical School at Houston, TX, USA; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
  • Department of Neurology, the University of Texas McGovern Medical School at Houston, TX, USA; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA; UTHealth Consortium on Aging, the Universit…

Förderung

  • NINDS NIH HHS
  • NIA NIH HHS
  • National Institute on Aging
  • Alzheimer's Association
  • Texas Alzheimer's Research and Care Consortium
  • Huffington Foundation
  • Glenn Foundation for Medical Research
  • American Federation for Aging Research

Zitieren

APA

Escarcega, R. D., M J, V. K., Kyriakopoulos, V. E., Ortiz, G. J., Gusdon, A. M., Fan, H., Peesh, P., Blasco Conesa, M. P., Colpo, G. D., Ahnstedt, H. W., Couture, L., Kim, S. H., Hinojosa, M., Farrell, C. M., Marrelli, S. P., Urayama, A., Ganesh, B. P., Schulz, P. E., McCullough, L. D., & Tsvetkov, A. S. (2025). Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106747

Vancouver

Escarcega RD, M J VK, Kyriakopoulos VE, Ortiz GJ, Gusdon AM, Fan H, et al. Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2024.106747

BibTeX
@article{Escarcega2025,
  author = {Escarcega, Rocio Diaz and M J, Vijay Kumar and Kyriakopoulos, Vasilia E and Ortiz, Guadalupe J and Gusdon, Aaron M and Fan, Huihui and Peesh, Pedram and Blasco Conesa, Maria P and Colpo, Gabriela Delevati and Ahnstedt, Hilda W and Couture, Lucy and Kim, Stella H and Hinojosa, Miriam and Farrell, Christine M and Marrelli, Sean P and Urayama, Akihiko and Ganesh, Bhanu P and Schulz, Paul E and McCullough, Louise D and Tsvetkov, Andrey S},
  title = {Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism},
  journal = {Neurobiology of Disease},
  year = {2025},
  doi = {10.1016/j.nbd.2024.106747}
}
Kostenlos starten →